Subphenotypic classification of COVID-19 survivors and response to telerehabilitation: a latent class analysis
DOI:
https://doi.org/10.2340/jrm.v57.42726Keywords:
COVID-19 Survivors, Telerehabilitation, latent class analysis, subphenotypesAbstract
Objective: Investigating the role of telerehabilitation in aiding recovery and societal reintegration for COVID-19 survivors, this study aims to identify distinct subphenotypes among survivors and assess their responsiveness to telerehabilitation.
Design: A secondary analysis of a multicentre, parallel-group randomized controlled trial from April 2020 through to follow-up in 2021.
Subjects/Patients: The study included 377 COVID-19 survivors (47.1% male), with a mean age of 56.4 years.
Methods: Data from the Telerehabilitation Programme for COVID-19 (TERECO) were analysed using Latent Class Analysis to identify subphenotypes based on baseline characteristics. Clinical outcomes were compared between subphenotypes and treatment groups.
Results: Latent Class Analysis identified 2 phenotypes: Phenotype 1 (52.9%) characterized by impaired lung function and Phenotype 2 (47.1%) with better lung function. Among those receiving corticosteroids, only Phenotype 1 showed significant benefits from the TERECO intervention. Discrimination accuracy using forced expiratory volume in 1 s (FEV1) and peak expiratory flow was high (AUC = 0.936).
Conclusion: Two distinct phenotypes were identified in COVID-19 survivors, suggesting potential improvements in clinical trial design and personalized treatment strategies based on initial pulmonary function. This insight can guide more targeted rehabilitation approaches, enhancing recovery outcomes for specific survivor groups.
Downloads
References
O’Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine 2023; 55: 101762.
https://doi.org/10.1016/j.eclinm.2022.101762 DOI: https://doi.org/10.1016/j.eclinm.2022.101762
Visan I. Long COVID. Nat Immunol 2021; 22: 934–935.
https://doi.org/10.1038/s41590-021-00992-4 DOI: https://doi.org/10.1038/s41590-021-00992-4
Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med 2021; 174: 1252–1260.
https://doi.org/10.7326/M21-0878 DOI: https://doi.org/10.7326/M21-0878
Regmi B, Friedrich J, Jörn B, Senol M, Giannoni A, Boentert M, et al. Diaphragm muscle weakness might explain exertional dyspnea 15 months after hospitalization for COVID-19. Am J Respir Crit Care Med 2023; 207: 1012–1021.
https://doi.org/10.1164/rccm.202206-1243OC DOI: https://doi.org/10.1164/rccm.202206-1243OC
Kostandova N, Schluth C, Arambepola R, Atuhaire F, Bérubé S, Chin T, et al. A systematic review of using population-level human mobility data to understand SARS-CoV-2 transmission. Nat Commun 2024; 15: 10504.
https://doi.org/10.1038/s41467-024-54895-7 DOI: https://doi.org/10.1038/s41467-024-54895-7
Hill NS. In persistent dyspnea after COVID-19 ARDS, exercise training rehabilitation vs. usual PT reduced dyspnea at 90 d. Ann Intern Med 2023; 176: Jc117.
https://doi.org/10.7326/J23-0073 DOI: https://doi.org/10.7326/J23-0073
McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015; 2015: Cd003793.
https://doi.org/10.1002/14651858.CD003793.pub3 DOI: https://doi.org/10.1002/14651858.CD003793.pub3
Lau HM, Ng GY, Jones AY, Lee EW, Siu EH, Hui DS. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother 2005; 51: 213–219.
https://doi.org/10.1016/S0004-9514(05)70002-7 DOI: https://doi.org/10.1016/S0004-9514(05)70002-7
Singh SJ, Baldwin MM, Daynes E, Evans RA, Greening NJ, Jenkins RG, et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. Lancet Respir Med 2023; 11: 709–725.
https://doi.org/10.1016/S2213-2600(23)00159-5 DOI: https://doi.org/10.1016/S2213-2600(23)00159-5
Vieira A, Pinto A, Garcia B, Eid RAC, Mól CG, Nawa RK. Telerehabilitation improves physical function and reduces dyspnoea in people with COVID-19 and post-COVID-19 conditions: a systematic review. J Physiother 2022; 68: 90–98.
https://doi.org/10.1016/j.jphys.2022.03.011 DOI: https://doi.org/10.1016/j.jphys.2022.03.011
Sonza A, da Cunha de Sá-Caputo D, Sartorio A, Tamini S, Seixas A, Sanudo B, et al. COVID-19 lockdown and the behavior change on physical exercise, pain and psychological well-being: an international multicentric study. Int J Environ Res Public Health 2021; 18: 3810.
https://doi.org/10.3390/ijerph18073810 DOI: https://doi.org/10.3390/ijerph18073810
Li J, Xia W, Zhan C, Liu S, Yin Z, Wang J, et al. A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial. Thorax 2022; 77: 697–706.
https://doi.org/10.1136/thoraxjnl-2021-217382 DOI: https://doi.org/10.1136/thoraxjnl-2021-217382
Mori M, Krumholz HM, Allore HG. Using Latent Class Analysis to identify hidden clinical phenotypes. JAMA 2020; 324: 700–701.
https://doi.org/10.1001/jama.2020.2278 DOI: https://doi.org/10.1001/jama.2020.2278
Dahmer MK, Yang G, Zhang M, Quasney MW, Sapru A, Weeks HM, et al. Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis. Lancet Respir Med 2022; 10: 289–297.
https://doi.org/10.1016/S2213-2600(21)00382-9 DOI: https://doi.org/10.1016/S2213-2600(21)00382-9
Sinha P, Delucchi KL, Thompson BT, McAuley DF, Matthay MA, Calfee CS. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med 2018; 44: 1859–1869.
https://doi.org/10.1007/s00134-018-5378-3 DOI: https://doi.org/10.1007/s00134-018-5378-3
Menéndez R, Méndez R, Latorre A, González-Jiménez P, Peces-Barba G, Molina-Molina M, et al. Clustering patients with COVID-19 according to respiratory support requirements, and its impact on short- and long-term outcome (RECOVID study). Pulmonology 2025; 31: 2442175.
https://doi.org/10.1080/25310429.2024.2442175 DOI: https://doi.org/10.1080/25310429.2024.2442175
Melo-Oliveira ME, Sá-Caputo D, Bachur JA, Paineiras-Domingos LL, Sonza A, Lacerda AC, et al. Reported quality of life in countries with cases of COVID19: a systematic review. Expert Rev Respir Med 2021; 15: 213–220.
https://doi.org/10.1080/17476348.2021.1826315 DOI: https://doi.org/10.1080/17476348.2021.1826315
Sañudo B, Seixas A, Gloeckl R, Rittweger J, Rawer R, Taiar R, et al. Potential application of whole body vibration exercise for improving the clinical conditions of COVID-19 infected individuals: a narrative review from the World Association of Vibration Exercise Experts (WAVex) Panel. Int J Environ Res Public Health 2020; 17: 3650.
https://doi.org/10.3390/ijerph17103650 DOI: https://doi.org/10.3390/ijerph17103650
Lo YT, Mendell NR, Rubin DB. Testing the number of components in a normal mixture. Biometrika 2001: 88: 767–778.
https://doi.org/10.1093/biomet/88.3.767 DOI: https://doi.org/10.1093/biomet/88.3.767
Schwarz GE. Estimating the dimension of a model. Ann Stat 1978; 6.
https://doi.org/10.1214/aos/1176344136 DOI: https://doi.org/10.1214/aos/1176344136
Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equ Modeling 2007; 14: 535–569.
https://doi.org/10.1080/10705510701575396 DOI: https://doi.org/10.1080/10705510701575396
Li P, Stuart EA, Allison DB. Multiple imputation: a flexible tool for handling missing data. JAMA 2015; 314: 1966–1967.
https://doi.org/10.1001/jama.2015.15281 DOI: https://doi.org/10.1001/jama.2015.15281
Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol 2015; 16: e173–180.
https://doi.org/10.1016/S1470-2045(14)71116-7 DOI: https://doi.org/10.1016/S1470-2045(14)71116-7
Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 2010; 5: 1315–1316.
https://doi.org/10.1097/JTO.0b013e3181ec173d DOI: https://doi.org/10.1097/JTO.0b013e3181ec173d
Sinha P, Calfee CS, Delucchi KL. Practitioner’s guide to latent class analysis: methodological considerations and common pitfalls. Crit Care Med 2021; 49: e63–e79.
https://doi.org/10.1097/CCM.0000000000004710 DOI: https://doi.org/10.1097/CCM.0000000000004710
Rugo HS, Olopade OI, DeMichele A, Yau C, van ‘t Veer LJ, Buxton MB, et al. Adaptive randomization of veliparib–carboplatin treatment in breast cancer. N Engl J Med 2016; 375: 23–34.
https://doi.org/10.1056/NEJMoa1513749 DOI: https://doi.org/10.1056/NEJMoa1513749
Gutiérrez-Gutiérrez B, Del Toro MD, Borobia AM, Carcas A, Jarrín I, Yllescas M, et al. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. Lancet Infect Dis 2021; 21: 783–792.
https://doi.org/10.1016/S1473-3099(21)00019-0 DOI: https://doi.org/10.1016/S1473-3099(21)00019-0
Azoulay E, Zafrani L, Mirouse A, Lengliné E, Darmon M, Chevret S. Clinical phenotypes of critically ill COVID-19 patients. Intensive Care Med 2020; 46: 1651–1652.
https://doi.org/10.1007/s00134-020-06120-4 DOI: https://doi.org/10.1007/s00134-020-06120-4
Nakamura H, Miyagi K, Otsuki M, Higure Y, Nishiyama N, Kinjo T, et al. Serum KL-6 can distinguish between different phenotypes of severe COVID-19. J Med Virol 2021; 93: 158–160.
https://doi.org/10.1002/jmv.26268 DOI: https://doi.org/10.1002/jmv.26268
Filippini DFL, Di Gennaro E, van Amstel RBE, Beenen LFM, Grasso S, Pisani L, et al. Latent class analysis of imaging and clinical respiratory parameters from patients with COVID-19-related ARDS identifies recruitment subphenotypes. Crit Care 2022; 26: 363.
https://doi.org/10.1186/s13054-022-04251-2 DOI: https://doi.org/10.1186/s13054-022-04251-2
Bos LDJ, Sjoding M, Sinha P, Bhavani SV, Lyons PG, Bewley AF, et al. Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts. Lancet Respir Med 2021; 9: 1377–1386.
https://doi.org/10.1016/S2213-2600(21)00365-9 DOI: https://doi.org/10.1016/S2213-2600(21)00365-9
RECOVERY Collaborative Group. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2023; 401: 1499–1507.
https://doi.org/10.1016/S0140-6736(23)00510-X DOI: https://doi.org/10.1016/S0140-6736(23)00510-X
Additional Files
Published
How to Cite
License
Copyright (c) 2025 Yide Wang, Qianqian Xue, Zheng Li, Fengsen Li
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.
